Concepedia

Naoki Terasaka

NT

14

Publications

2.9K

Citations

14

H-Index

2002

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Daiichi Sankyo (Germany)

Columbia University

Biomedical Research Laboratories (United States)

Naoki Terasaka is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and atherosclerosis.

ORCID

Top concepts

Publications per year

2002–2020

14

Publications

14

Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice

Yoshihisa Okamoto, Shinji Kihara, Noriyuki Ouchi et al. · Circulation · 2002 · 1K citations

Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice

Laurent Yvan‐Charvet, Mollie Ranalletta, Nan Wang et al. · Journal of Clinical Investigation · 2007 · 526 citations · Full text

T‐0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor‐deficient mice

Naoki Terasaka, Ayano Hiroshima, Tadashi Koieyama et al. · FEBS Letters · 2002 · 322 citations

High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1

Naoki Terasaka, Nan Wang, Laurent Yvan‐Charvet et al. · Proceedings of the National Academy of Sciences · 2007 · 270 citations · Full text

, , +17

ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet

Naoki Terasaka, Shuiqing Yu, Laurent Yvan‐Charvet et al. · Journal of Clinical Investigation · 2008 · 226 citations · Full text

Rows per page

1–5 of 14